Molecular Networks GmbH
Molecular Networks GmbH (MN-AM) develops chemoinformatics software, including the ChemTunes·ToxGPS toxicity platform and CORINA 3D structure generator, for chemical safety and risk assessment across pharmaceutical, chemical, biotechnology, and cosmetics industries and regulatory agencies.
- Company typePrivate
- Founded1997
- HeadquartersErlangen, Germany
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Molecular Networks GmbH does
Molecular Networks GmbH - Computerchemie, operating jointly with its U.S. subsidiary Altamira LLC under the MN-AM brand, develops and sells chemoinformatics software for chemical safety and risk assessment. Founded in 1997 and headquartered in Nuremberg, Germany with a U.S. office in Columbus, Ohio, the company builds two core product lines: ChemTunes·ToxGPS, a chemoinformatics platform paired with an expert-curated toxicity knowledge base that supports read-across workflows, point-of-departure estimation, and regulatory frameworks including ICH M7, REACH, TTC, and next-generation risk assessment; and CORINA Classic, a 3D molecular structure generator with documented performance for large-scale chemistry datasets. Adjacent offerings include CORINA Symphony (an advanced version integrating Cepos InSilico's EMPIRE semi-empirical quantum-mechanical parameter calculation) and a public COSMOS NG knowledge base. The company was acquired by Lhasa Limited in January 2025 and now operates as a wholly-owned subsidiary.
MN-AM serves pharmaceutical, chemical, biotechnology, and cosmetics enterprises alongside regulatory agencies such as the US FDA and US EPA. Its go-to-market combines enterprise field sales with a strong conference presence at SOT, EUROTOX, ASCCT, and SITOX, complemented by OEM/ISV integrations into BIOVIA's pipeline, Chemical Computing Group's Molecular Operating Environment, Inte:Ligand's ilib diverse library generator, and BioSolveIT's FlexX docking program. Named enterprise customers include L'Oréal, Unilever, Roche, and Procter & Gamble. Revenue is generated through quote-based annual software subscriptions for ChemTunes·ToxGPS and CORINA, with additional revenue likely from licensing royalties and scientific consulting.
The business model is enterprise software licensing on a subscription cadence with quote-based, non-public pricing. Revenue mechanics combine direct enterprise subscriptions, OEM/embedded royalties through integration partners, and grant-funded research collaborations with EU and U.S. agencies (COSMOS, ONTOX, FDA, EPA). The 11-50 employee headcount is small relative to enterprise customers' regulatory and R&D budgets, reflecting a high-value, specialty-tool vendor profile rather than a horizontal SaaS model.
Molecular Networks GmbH firmographics
Firmographics- Name
- Molecular Networks GmbH
- Legal name
- Molecular Networks GmbH – Computerchemie
- Website
- https://mn-am.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Molecular Networks GmbH (MN-AM) develops chemoinformatics software, including the ChemTunes·ToxGPS toxicity platform and CORINA 3D structure generator, for chemical safety and risk assessment across pharmaceutical, chemical, biotechnology, and cosmetics industries and regulatory agencies.
- Ownership category
- akta.pro rank
Molecular Networks GmbH industry classification
Industry- Product category
- Chemoinformatics Software
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Cheminformatics & Molecular Modeling / CADD (HLAGAJAE)
- akta.pro secondary industry
- In Silico / Computational Toxicology & PK/PD Modeling (HLAGAFAM)
Keywords
Where Molecular Networks GmbH is headquartered
LocationHeadquarters
- HQ city
- Erlangen
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Molecular Networks GmbH business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Licensing and Subscriptions: MN-AM provides software products including CORINA Classic and ChemTunes·ToxGPS to pharmaceutical, chemical, and biotechnology companies for computational toxicology and chemical safety assessment. Revenue is generated through software licensing, subscriptions, and potentially professional services for implementation and training.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise software licensing |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Molecular Networks GmbH product offering
Product offeringCore offering
Molecular Networks GmbH (MN-AM) develops and sells chemoinformatics software for chemical safety assessment, computational toxicology, and molecular modeling. Its core offerings are ChemTunes·ToxGPS, a chemoinformatics platform with an expert-reviewed toxicity knowledgebase for in silico prediction of human health endpoints and read-across workflows, and CORINA Classic, a 3D molecular structure generator used in big-data chemistry applications.
Product overview
MN-AM offers a suite of chemoinformatics software solutions for the chemical, biotechnology, and pharmaceutical industries. The product portfolio centers on two core commercial products: ChemTunes·ToxGPS (a chemoinformatics platform and toxicity knowledgebase for chemical safety and risk assessment) and CORINA Classic (a 3D structure generator). Additional offerings include CORINA Symphony (advanced version with quantum mechanical calculations) and the public COSMOS Next Generation platform. These tools provide capabilities spanning from 3D molecular structure generation to toxicity predictions, read-across workflows, and regulatory safety assessment support.
Differentiator
Problem solved
Functional benefit
Products and services
- ChemTunes·ToxGPS A unique chemoinformatics platform and toxicity knowledgebase supporting chemical safety and risk assessment of human health and regulatory-relevant endpoints. Provides expert-reviewed toxicity database, MoA-based in silico predictions, bioavailability data, POD bounds calculator, and read-across workflows for specific chemical domains. Used by pharmaceutical, chemical, and biotechnology companies for computational toxicology and regulatory safety assessment.
- CORINA Classic A fast, reliable, and robust 3D molecular structure generator with broad scope of application and covered chemical space, providing excellent performance for big-data chemistry applications. Used by computational chemists and life science researchers for 3D molecular structure generation.
- CORINA Symphony Advanced chemoinformatics application offering optional quantum mechanical parameter calculations based on the EMPIRE semi-empirical molecular orbital program from Cepos InSilico. Provides enhanced molecular modeling capabilities beyond CORINA Classic for users requiring quantum-mechanical descriptors.
- COSMOS Next Generation (COSMOS NG) Public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals, providing toxicity data and workflows for chemical safety assessment as the public version complementary to the commercial ChemTunes·ToxGPS platform.
Companies that use Molecular Networks GmbH
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles4 records
Molecular Networks GmbH technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability5 records
Feature4 records
Molecular Networks GmbH partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- Lhasa LimitedcoreAcquired by Lhasa Limited in January 2025. Lhasa is described as the leader in decision making software for in silico chemical safety. The acquisition brings together MN-AM's chemoinformatics platform with Lhasa's computational toxicology solutions.
- BIOVIA (Dassault Systèmes)coreMolecular Networks partners the Independent Software Vendor (ISV) Program of BIOVIA, distributing CORINA technology through BIOVIA's channel to their extensive customer base in pharmaceutical and chemical industries.
- Chemical Computing Group (CCG)coreSince version 2007.09, CCG's Molecular Operating Environment (MOE) provides an interface to seamlessly integrate CORINA, enabling computational chemists to use 3D structure generation within the MOE workflow.
- Biomax Informatics AGminorStrategic partnership to effectively join bioinformatics and chemoinformatics into one stream of research, combining the strengths of both companies' technology platforms.
- BioSolveIT GmbHminorBioSolveIT and Molecular Networks collaborate for joint marketing on the North American market and for a seamless interface between BioSolveIT's premium docking program FlexX and CORINA.
- S-IN Soluzioni Informatiche SrlminorCollaboration in providing services and consulting in computational toxicology in compliance with REACH and ICH M7 regulatory guidelines by sharing complementary state-of-the-art technology and expert knowledge.
- COSMOS ProjectcoreEU FP7/Cosmetics Europe project where Altamira is the US partner and Molecular Networks is the EU partner. Contributed to the COSMOS NG public knowledge base for chemical safety assessment.
- US FDA (Center for Food Safety and Applied Research)coreCollaboration partner for chemical safety assessment, including evaluation of FDA's chemical inventories for human health endpoints and support for FDA's CERES project.
- US EPA (National Center for Computational Toxicology)coreCollaboration partner contributing to computational toxicology initiatives including ToxCast data analysis and development of chemoinformatics approaches.
- The Ohio State UniversitycoreAcademic collaboration partner in the Department of Chemical and Biomolecular Engineering, working on translational safety assessment and DILI prediction tools.
- ACC Biocides PanelminorPrevious research sponsor for Antimicrobial (AM) TTC Project, demonstrating applicability of TTC approach to evaluation of antimicrobial pesticides.
- ONTOX Project ConsortiumcoreEuropean research project on safer chemicals using less animals. MN-AM contributes to developing novel in silico methods to predict toxicity of chemicals without animal testing.
Scale indicators3 records
Recent moves5 records
Expansion highlights6 records
Molecular Networks GmbH competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Molecular Networks GmbH social profiles
Digital presenceMolecular Networks GmbH compliance and trust
Trust signalCompliance1 record
Molecular Networks GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
Molecular Networks GmbH leadership team
Management profileNumber of profiles
Profiles2 records
Molecular Networks GmbH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Molecular Networks GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Molecular Networks GmbH
What does Molecular Networks GmbH do?
Molecular Networks GmbH (MN-AM) develops and sells chemoinformatics software for chemical safety assessment, computational toxicology, and molecular modeling. Its core offerings are ChemTunes·ToxGPS, a chemoinformatics platform with an expert-reviewed toxicity knowledgebase for in silico prediction of human health endpoints and read-across workflows, and CORINA Classic, a 3D molecular structure generator used in big-data chemistry applications.
Is Molecular Networks GmbH a public or private company?
Molecular Networks GmbH is a private company. It is classified as corporate owned and is currently operating.
When was Molecular Networks GmbH founded?
Molecular Networks GmbH was founded in 1997. It employs 1 to 10 people.
Where is Molecular Networks GmbH based?
Molecular Networks GmbH is headquartered in Erlangen, Germany, in the Europe region.
How does Molecular Networks GmbH make money?
One revenue line is on record: software Licensing and Subscriptions.
Does Molecular Networks GmbH have an API?
No public API is recorded for Molecular Networks GmbH.
What industry is Molecular Networks GmbH in?
Molecular Networks GmbH's product category is Chemoinformatics Software. Its primary akta.pro industry code is HLAGAJAE, Cheminformatics & Molecular Modeling / CADD, with a secondary code of HLAGAFAM, In Silico / Computational Toxicology & PK/PD Modeling. Its NAICS code is 541714 and its SIC code is 8731.